《EJNMMI,2月28日,Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-01
  • Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

    Xi Xu, Chengcheng Yu, Jing Qu, Lieguang Zhang, Songfeng Jiang, Deyang Huang, Bihua Chen, Zhiping Zhang, Wanhua Guan, Zhoukun Ling, Rui Jiang, Tianli Hu, Yan Ding, Lin Lin, Qingxin Gan, Liangping Luo, Xiaoping Tang & Jinxin Liu

    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Abstract

    Background

    The pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2, also called 2019-nCoV) recently break out in Wuhan, China, and was named as COVID-19. With the spread of the disease, similar cases have also been confirmed in other regions of China. We aimed to report the imaging and clinical characteristics of these patients infected with SARS-CoV-2 in Guangzhou, China.

  • 原文来源:https://doi.org/10.1007/s00259-020-04735-9
相关报告
  • 《INFECTION,2月25日,Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-01
    • Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2 Yu-HuanXua1Jing-HuiDonga1Wei-minAna1Xiao-YanLvaXiao-PingYinbJian-ZengZhangaLiDongcXiMabHong-JieZhangdBu-LangGaoa Show more https://doi.org/10.1016/j.jinf.2020.02.017 Abstract Purpose : To investigate the clinical and imaging characteristics of computed tomography (CT) in novel coronavirus pneumonia (NCP) caused by SARS-CoV-2.
  • 《CID,3月28日,Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-29
    • Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 Juanjuan Zhao, Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li ... Show more Author Notes Clinical Infectious Diseases, ciaa344, https://doi.org/10.1093/cid/ciaa344 Published: 28 March 2020 Abstract Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated. Methods A total of 173 patients with SARS-CoV-2 infection were enrolled. Their serial plasma samples (n=535) collected during the hospitalization were tested for total antibodies (Ab), IgM and IgG against SARS-CoV-2. The dynamics of antibodies with the disease progress was analyzed.